Amedeo Smart

Free Medical Literature Service



Alzheimer's Disease

  Free Subscription


1 Acta Neuropathol
5 Alzheimers Dement
2 BMC Geriatr
1 Brain
1 Curr Alzheimer Res
1 Exp Gerontol
1 Exp Neurol
2 J Neurosci
1 Nat Neurosci
2 Nat Rev Neurol
2 Neurobiol Aging
3 Neurochem Res
1 Neurol Clin Pract
2 Neurology
3 PLoS One
2 Science

    Acta Neuropathol

  1. ANDO K, Kucukali F, Doeraene E, Nagaraj S, et al
    Alteration of gene expression and protein solubility of the PI 5-phosphatase SHIP2 are correlated with Alzheimer's disease pathology progression.
    Acta Neuropathol. 2024;147:94.
    >> Share

    Alzheimers Dement

  2. ARBER C, Belder CRS, Tomczuk F, Gabriele R, et al
    The presenilin 1 mutation P436S causes familial Alzheimer's disease with elevated Abeta43 and atypical clinical manifestations.
    Alzheimers Dement. 2024 Jun 2. doi: 10.1002/alz.13904.
    >> Share

  3. LIU ZT, Liu MH, Xiong Y, Wang YJ, et al
    Crosstalk between bone and brain in Alzheimer's disease: Mechanisms, applications, and perspectives.
    Alzheimers Dement. 2024 Jun 2. doi: 10.1002/alz.13864.
    >> Share

  4. GUPTARAK J, Scaduto P, Tumurbaatar B, Zhang WR, et al
    Cognitive integrity in Non-Demented Individuals with Alzheimer's Neuropathology is associated with preservation and remodeling of dendritic spines.
    Alzheimers Dement. 2024 Jun 3. doi: 10.1002/alz.13900.
    >> Share

  5. SIRKIS DW, Warly Solsberg C, Johnson TP, Bonham LW, et al
    Expansion of highly interferon-responsive T cells in early-onset Alzheimer's disease.
    Alzheimers Dement. 2024 Jun 3. doi: 10.1002/alz.13892.
    >> Share

  6. YERRAMALLA MS, Darin-Mattsson A, Udeh-Momoh CT, Holleman J, et al
    Cognitive reserve, cortisol, and Alzheimer's disease biomarkers: A memory clinic study.
    Alzheimers Dement. 2024 Jun 4. doi: 10.1002/alz.13866.
    >> Share

    BMC Geriatr

  7. XU B, Ling Y, Liu L, Liu Y, et al
    Potential prognostic value of CSF-targeted proteomics across the Alzheimer's disease continuum.
    BMC Geriatr. 2024;24:501.
    >> Share

  8. YUAN Y, Yang Y, Hu X, Zhang L, et al
    Effective dosage and mode of exercise for enhancing cognitive function in Alzheimer's disease and dementia: a systematic review and Bayesian Model-Based Network Meta-analysis of RCTs.
    BMC Geriatr. 2024;24:480.
    >> Share


  9. COOMANS EM, Ossenkoppele R
    The implications of amyloid-beta pathology: only time will tell.
    Brain. 2024;147:1934-1936.
    >> Share

    Curr Alzheimer Res

  10. MALEKI SF, Yousefi M, Sobhi N, Jafarizadeh A, et al
    Artificial Intelligence in Eye Movements Analysis for Alzheimer's Disease Early Diagnosis.
    Curr Alzheimer Res. 2024 Jun 4. doi: 10.2174/0115672050322607240529075641.
    >> Share

    Exp Gerontol

  11. SAFARZADEH E, Ataei S, Akbari M, Abolhasani R, et al
    Quercetin ameliorates cognitive deficit, expression of amyloid precursor gene, and pro-inflammatory cytokines in an experimental models of Alzheimer's disease in Wistar rats.
    Exp Gerontol. 2024;193:112466.
    >> Share

    Exp Neurol

  12. HUANG XY, Xue LL, Ma RF, Shi JS, et al
    Inhibition of CXCR4: A perspective on miracle fruit seed for Alzheimer's disease treatment.
    Exp Neurol. 2024 May 29:114841. doi: 10.1016/j.expneurol.2024.114841.
    >> Share

    J Neurosci

  13. TOSI G, Nigro S, Urso D, Spinosa V, et al
    The network structure of cognitive impairment: from Subjective Cognitive Decline to Alzheimer's Disease.
    J Neurosci. 2024 Jun 3:e1344232023. doi: 10.1523/JNEUROSCI.1344-23.2023.
    >> Share

  14. ETXEBERRIA A, Shen YA, Vito S, Silverman S, et al
    Neutral or detrimental effects of TREM2 agonist antibodies in preclinical models of Alzheimer's Disease and Multiple Sclerosis.
    J Neurosci. 2024 Jun 3:e2347232024. doi: 10.1523/JNEUROSCI.2347-23.2024.
    >> Share

    Nat Neurosci

  15. BENJAMIN KJM, Chen Q, Eagles NJ, Huuki-Myers LA, et al
    Analysis of gene expression in the postmortem brain of neurotypical Black Americans reveals contributions of genetic ancestry.
    Nat Neurosci. 2024;27:1064-1074.
    >> Share

    Nat Rev Neurol

  16. WOOD H
    Microglial senescence is a potential therapeutic target for Alzheimer disease.
    Nat Rev Neurol. 2024 Jun 4. doi: 10.1038/s41582-024-00979.
    >> Share

  17. FYFE I
    APOE alpha4 homozygosity - a genetic form of Alzheimer disease?
    Nat Rev Neurol. 2024 Jun 4. doi: 10.1038/s41582-024-00985.
    >> Share

    Neurobiol Aging

  18. KNUDTZON SL, Nordengen K, Grontvedt GR, Jarholm J, et al
    Age-adjusted CSF t-tau and NfL do not improve diagnostic accuracy for prodromal Alzheimer's disease.
    Neurobiol Aging. 2024;141:74-84.
    >> Share

  19. BERNOCCHI F, Bonomi CG, Assogna M, Moreschini A, et al
    Astrocytic-derived vascular remodeling factors are independently associated with blood brain barrier permeability in Alzheimer's disease.
    Neurobiol Aging. 2024;141:66-73.
    >> Share

    Neurochem Res

  20. GAYGER-DIAS V, Menezes L, Da Silva VF, Stiborski A, et al
    Changes in Astroglial Water Flow in the Pre-amyloid Phase of the STZ Model of AD Dementia.
    Neurochem Res. 2024;49:1851-1862.
    >> Share

  21. WANG XF, Xiang XH, Wei J, Zhang PB, et al
    Raddeanin A Protects the BRB Through Inhibiting Inflammation and Apoptosis in the Retina of Alzheimer's Disease.
    Neurochem Res. 2024 Jun 4. doi: 10.1007/s11064-024-04145.
    >> Share

  22. SHENG L, Bhalla R
    Biomarkers and Target-Specific Small-Molecule Drugs in Alzheimer's Diagnostic and Therapeutic Research: From Amyloidosis to Tauopathy.
    Neurochem Res. 2024 Jun 6. doi: 10.1007/s11064-024-04178.
    >> Share

    Neurol Clin Pract

  23. HANCOCK LM, Galioto R, Rhoads T, Ontaneda D, et al
    Comparing Cognitive Profiles in Older Adults With Multiple Sclerosis and Alzheimer Disease: More Similarities Than Differences.
    Neurol Clin Pract. 2024;14:e200327.
    >> Share


  24. BOLSEWIG K, van Unnik AAJM, Blujdea ER, Gonzalez MC, et al
    Association of Plasma Amyloid, P-Tau, GFAP, and NfL With CSF, Clinical, and Cognitive Features in Patients With Dementia With Lewy Bodies.
    Neurology. 2024;102:e209418.
    >> Share

  25. SUN M, He Q, Sun N, Han Q, et al
    Intrinsic Capacity, Polygenic Risk Score, APOE Genotype, and Risk of Dementia: A Prospective Cohort Study Based on the UK Biobank.
    Neurology. 2024;102:e209452.
    >> Share

    PLoS One

  26. LOPES DA CUNHA P, Ruiz F, Ferrante F, Sterpin LF, et al
    Automated free speech analysis reveals distinct markers of Alzheimer's and frontotemporal dementia.
    PLoS One. 2024;19:e0304272.
    >> Share

  27. DENKINGER M, Baker S, Inglis B, Kobayashi S, et al
    Associations between regional blood-brain barrier permeability, aging, and Alzheimer's disease biomarkers in cognitively normal older adults.
    PLoS One. 2024;19:e0299764.
    >> Share

  28. AZMAL M, Hossen MS, Shohan MNH, Taqui R, et al
    A computational approach to identify phytochemicals as potential inhibitor of acetylcholinesterase: Molecular docking, ADME profiling and molecular dynamics simulations.
    PLoS One. 2024;19:e0304490.
    >> Share


  29. TOPOL EJ
    Medical forecasting.
    Science. 2024;384:eadp7977.
    >> Share

  30. PILLER C
    Authors move to retract discredited Alzheimer's study.
    Science. 2024;384:1055.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016